Loading clinical trials...
Loading clinical trials...
\- The investigators propose a clinical trial to evaluate the impact of annual shared decision making for PSA screening, supported by system-level enhancements to promote evidence-based care: * Defined referral thresholds within the health maintenance reminder, aligned with clinical risk stratification per NCCN guidelines. * Enhanced clinical decision support (CDS) tools to reduce provider variation and ensure guideline-concordant screening and referral practices. * The goal is to reduce late-stage presentation without increasing overdiagnosis-ensuring that prostate cancer screening is both accessible and clinically effective.
Age
40 - 75 years
Sex
MALE
Healthy Volunteers
Yes
Washington University School of Medicine
St Louis, Missouri, United States
Start Date
August 11, 2025
Primary Completion Date
August 31, 2031
Completion Date
August 31, 2031
Last Updated
August 17, 2025
40,000
ESTIMATED participants
Annual PSA Health Maintenance Reminder
OTHER
Lead Sponsor
Washington University School of Medicine
NCT06842498
NCT04550494
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT05691465